Peptide library / Skin & aging / Dipeptide diaminobutyroyl benzylamide diacetate
Dipeptide diaminobutyroyl benzylamide diacetate
A tiny synthetic molecule modeled on snake venom, marketed as a topical wrinkle reducer.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Reduce expression lines, topicalLab
How it is thought to work
It imitates waglerin-1 from the temple viper and acts on muscle acetylcholine receptors to briefly reduce contraction.
What the evidence shows
Support comes from manufacturer studies. It is not a toxin and is not a substitute for injections.
Safety and unknowns
Well tolerated in topical products.
Regulatory status
Cosmetic ingredient, not a drug.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Skin & aging
FOXO4-DRI
In clinical trialsA designer peptide that triggers aged senescent cells to self-destruct, shown in mice.
GHK-Cu
Cosmetic and topicalA natural copper-binding tripeptide used widely in skin creams and promoted as an injectable.
Difelikefalin
FDA-approvedA kappa opioid receptor agonist peptide that relieves itch in people on dialysis.
General information, not medical advice. Do not buy or inject unregulated peptides.